Bank of New York Mellon’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $289K | Sell |
99,889
-564
| -0.6% | -$1.63K | ﹤0.01% | 3804 |
|
|
2025
Q1 | $216K | Hold |
100,453
| – | – | ﹤0.01% | 3836 |
|
|
2024
Q4 | $389K | Buy |
100,453
+1,823
| +2% | +$7.06K | ﹤0.01% | 3626 |
|
|
2024
Q3 | $646K | Sell |
98,630
-36,247
| -27% | -$237K | ﹤0.01% | 3361 |
|
|
2024
Q2 | $978K | Buy |
134,877
+49,102
| +57% | +$356K | ﹤0.01% | 3211 |
|
|
2024
Q1 | $651K | Sell |
85,775
-10,989
| -11% | -$83.4K | ﹤0.01% | 3363 |
|
|
2023
Q4 | $440K | Sell |
96,764
-1,074
| -1% | -$4.89K | ﹤0.01% | 3619 |
|
|
2023
Q3 | $386K | Hold |
97,838
| – | – | ﹤0.01% | 3679 |
|
|
2023
Q2 | $306K | Buy |
97,838
+69,021
| +240% | +$216K | ﹤0.01% | 3813 |
|
|
2023
Q1 | $131K | Hold |
28,817
| – | – | ﹤0.01% | 4022 |
|
|
2022
Q4 | $119K | Buy |
28,817
+9,844
| +52% | +$40.7K | ﹤0.01% | 4087 |
|
|
2022
Q3 | $60K | Hold |
18,973
| – | – | ﹤0.01% | 4291 |
|
|
2022
Q2 | $37K | Hold |
18,973
| – | – | ﹤0.01% | 4406 |
|
|
2022
Q1 | $77K | Hold |
18,973
| – | – | ﹤0.01% | 4452 |
|
|
2021
Q4 | $205K | Hold |
18,973
| – | – | ﹤0.01% | 4265 |
|
|
2021
Q3 | $219K | Hold |
18,973
| – | – | ﹤0.01% | 4171 |
|
|
2021
Q2 | $187K | Hold |
18,973
| – | – | ﹤0.01% | 4109 |
|
|
2021
Q1 | $277K | Buy |
+18,973
| New | +$277K | ﹤0.01% | 3938 |
|
|
2019
Q4 | – | Sell |
-2,094
| Closed | -$19K | – | 4212 |
|
|
2019
Q3 | $19K | Hold |
2,094
| – | – | ﹤0.01% | 4175 |
|
|
2019
Q2 | $30K | Sell |
2,094
-6,682
| -76% | -$95.7K | ﹤0.01% | 4153 |
|
|
2019
Q1 | $288K | Sell |
8,776
-4,687
| -35% | -$154K | ﹤0.01% | 3752 |
|
|
2018
Q4 | $800K | Buy |
13,463
+392
| +3% | +$23.3K | ﹤0.01% | 3229 |
|
|
2018
Q3 | $1.83M | Buy |
13,071
+2,378
| +22% | +$334K | ﹤0.01% | 2885 |
|
|
2018
Q2 | $1.31M | Buy |
10,693
+3,349
| +46% | +$411K | ﹤0.01% | 3101 |
|
|
2018
Q1 | $656K | Buy |
7,344
+46
| +0.6% | +$4.11K | ﹤0.01% | 3436 |
|
|
2017
Q4 | $405K | Buy |
7,298
+4,245
| +139% | +$236K | ﹤0.01% | 3685 |
|
|
2017
Q3 | $129K | Buy |
3,053
+48
| +2% | +$2.03K | ﹤0.01% | 3960 |
|
|
2017
Q2 | $126K | Sell |
3,005
-5,678
| -65% | -$238K | ﹤0.01% | 3979 |
|
|
2017
Q1 | $485K | Buy |
8,683
+483
| +6% | +$27K | ﹤0.01% | 3564 |
|
|
2016
Q4 | $313K | Buy |
8,200
+2,422
| +42% | +$92.5K | ﹤0.01% | 3771 |
|
|
2016
Q3 | $230K | Sell |
5,778
-1,398
| -19% | -$55.6K | ﹤0.01% | 3853 |
|
|
2016
Q2 | $515K | Sell |
7,176
-644
| -8% | -$46.2K | ﹤0.01% | 3524 |
|
|
2016
Q1 | $627K | Buy |
7,820
+1,565
| +25% | +$125K | ﹤0.01% | 3326 |
|
|
2015
Q4 | $473K | Sell |
6,255
-5
| -0.1% | -$378 | ﹤0.01% | 3535 |
|
|
2015
Q3 | $2.4M | Sell |
6,260
-651
| -9% | -$250K | ﹤0.01% | 2618 |
|
|
2015
Q2 | $2.87M | Buy |
6,911
+2,819
| +69% | +$1.17M | ﹤0.01% | 2684 |
|
|
2015
Q1 | $1.95M | Buy |
4,092
+1,533
| +60% | +$729K | ﹤0.01% | 2886 |
|
|
2014
Q4 | $947K | Buy |
2,559
+1,199
| +88% | +$444K | ﹤0.01% | 3341 |
|
|
2014
Q3 | $320K | Buy |
+1,360
| New | +$320K | ﹤0.01% | 3761 |
|